Former Top Industry Insider Reveals Big Pharma Secrets

• Insider tells how bribery is common practice in drug approvals.

• Admits he pushed drugs worldwide he knew weren’t safe.

By Dave Gahary —

The former managing director of drug giant Eli Lilly and Company in Sweden continues to blow the whistle on the business practices of the pharmaceutical industry, scoring a major victory in announcing that his first book, Side Effects: Death. Confessions of a Pharma-Insider, will be turned into a full-length feature film.

John Virapen, who began his career with “Big Pharma” in 1968 as a salesman knocking on doctors’ doors, rose through the ranks to realize what he was pitching were not drugs, but death. Virapen was well aware early on that thousands had died or committed suicide by taking the drugs he was pushing. “I indirectly contributed to the death of . . . people, whose shadows now haunt me,” he explained in his book.

Spending nearly 30 years pushing Big Pharma’s wares onto doctors, who would then push them onto an unsuspecting, trusting public, Virapen made millions dealing drugs, crisscrossing the globe in the hopes of convincing healthcare professionals to use his company’s products, even when he knew they were unsafe.


Podcast Play Button


Seeing his latest son born in 2004 was an epiphany for him, and he decided to come out of the shadows to make sure no one else died at the hands of pharmaceuticals. Virapen is now 71 years old.

Virapen played a key role in getting approval for the drug Prozac (fluoxetine) in Sweden, a country that other nations look to as the leader in drug approvals. Virapen resides there now.

“Sweden was the frontrunner when it came to registration of drugs,” he explained to this reporter during an August 14 interview. “Even the FDA used to go to them and ask questions.”

Prozac, used to treat clinical depression and prescribed to more than 54 million people worldwide, is mind-altering and responsible, many feel, for the rash of school shootings afflicting America primarily, but other countries as well.



Side Effects: Death is the true story of corruption, bribery and fraud written by Dr. John Virapen, who has been called THE Big Pharma Insider. During his 35 years in the pharmaceutical industry internationally (most notably as general manager of Eli Lilly and Company in Sweden), Virapen was responsible for the marketing of several drugs, all of them with side effects.

Now, Virapen is coming clean and telling all of the little secrets you were never intended to know!

Softcover, 194 pages

Buy Book ButtonAMERICAN FREE PRESS asked Virapen to explain how he helped get Prozac into the hands of millions.

“My boss told me, ‘Do what you have to do’ to get the drug approved,” he said.

Finding the man responsible for the approval, and researching his background for clues on how to best approach him, they met at an Indian restaurant to discuss Virapen’s proposal.

“He was laughing,” Virapen told this reporter, “and I asked him, ‘What are you laughing at?’”

“He told me, ‘This product is no good, it’s a load of rubbish,’ ” said Virapen.

Around a month later, Virapen’s target received a $25,000 check from Lilly, a bribe, plus a promise to do a 10-year study on the drug, “which meant millions for him,” Virapen explained.

“I had performed a criminal act,” he wrote in his book. “I was forced to use bribery to influence drug approval, even though I knew the drug would harm people.”

In another transaction, in 15 minutes, he got a $500,000 government contract to buy insulin in exchange for a $10,000 computer system.

This practice is part of the daily routine in the pharmaceutical industry, Virapen said.

“All the companies were the same,” said Virapen. “I did a lot of bribery. I’m an expert.”

“We’d send doctors and their wives away on vacation somewhere,” he continued. “Or we’d give them a new refrigerator. In America, I think they’d get swimming pools. Psychiatrists, they’d get a Picasso.”

Over the course of nearly three decades of working in the pharmaceutical business, Virapen said he only came across one person he couldn’t bribe.

“The pharmaceutical industry’s lobby is extremely powerful,” he wrote in his book. “It constantly lobbies politicians and the judiciary and even blackmails governments by threatening to withdraw investments or to close down sites, thus, creating unemployment in a country.”

AFP asked what he hoped to gain from exposing the corruption.

“I want to see chemical medicine taken out of the equation,” he said.

Donate to us

Dave Gahary, a former submariner in the U.S. Navy, is the host of AFP’s ‘Underground Interview’ series.

Be sure to check out all of AFP’s free audio interviews. You’ll find them on the HOME PAGE, ARCHIVES & AUDIO section.

4 Comments on Former Top Industry Insider Reveals Big Pharma Secrets

  1. I read John Virapen’s book.

    Guess what happened to the professor who took Virapen’s bribe? He became promoted to a member of Swedish scientific advisory board. After the book came out!

    The whole establishment is corrupt. I believe they are cabbalistic satanists.

  2. It’s freaks like you that got us into this mess. I have learned from you your government and institutions.

    So you go f*** yourself, pr**ck.

  3. I am glad this guy came forward and now gives the information to the public, but after 30 years of being corrupt and profiting personally in the MILLIONS off of harming and murdering people, now he wants to be honest and tell the truth in a book that costs consumers $25 to buy and profit off of a movie?! (I’m sure he’s retired at this point in his 70s, so no sweat off his back). How convenient. F*ck him, really.

    The noble thing to do would’ve been to come out w/it 30 years ago and refuse to engage in the criminal act and expose them. Being honest 30 years later after you damaged and killed people b/c of your willingness to commit fraud is hardly excusable, and I wish criminals like this and everyone involved (including the doctors who took bribes) would be punished harshly w/prison time for their far-too-late admissions of murder and fraud.

Comments are closed.